tiprankstipranks
Good Fellow Healthcare Holdings Limited (HK:8143)
:8143
Hong Kong Market

Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

0 Followers

Top Page

HK:8143

Good Fellow Healthcare Holdings Limited

(8143)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
HK$0.11
▼(-42.11% Downside)
Action:UpgradedDate:03/24/26
The score is held down primarily by weak financial performance: sustained losses, sharp revenue decline, and negative equity in FY2025 signal elevated fundamental risk despite improved FY2025 operating/free cash flow. Technicals add modest pressure as the stock trades below key longer-term moving averages with a negative MACD. Valuation remains constrained by loss-making results (negative P/E) and no indicated dividend yield.
Positive Factors
Improved cash generation
A return to positive operating and free cash flow in FY2025 provides durable runway to fund operations and short-term obligations without immediate external financing. If sustained, this improves liquidity, reduces refinancing risk, and enables reinvestment or deleveraging over several quarters.
Negative Factors
Negative shareholders' equity
Negative shareholders’ equity signals cumulative losses that erode the capital base, raising long-term solvency and funding concerns. This structural weakness constrains access to capital, limits strategic flexibility, and increases the risk of covenant breaches or dilution if external capital is required.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved cash generation
A return to positive operating and free cash flow in FY2025 provides durable runway to fund operations and short-term obligations without immediate external financing. If sustained, this improves liquidity, reduces refinancing risk, and enables reinvestment or deleveraging over several quarters.
Read all positive factors

Good Fellow Healthcare Holdings Limited (8143) vs. iShares MSCI Hong Kong ETF (EWH)

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company Description
Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup...
How the Company Makes Money
null...

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary
Financial performance is weak, driven by persistent net losses (FY2020–FY2025) and severe revenue contraction (about 144.6M in FY2020 to ~16.1M in FY2025). The balance sheet is a major risk with negative shareholders’ equity in FY2025 (~-6.5M). The main offset is improved cash generation in FY2025 with positive operating and free cash flow (~2.6M), but cash-flow history is volatile and profitability remains unproven.
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
36
Negative
BreakdownMar 2024Mar 2023Mar 2022Mar 2021Mar 2021
Income Statement
Total Revenue16.12M38.96M55.35M54.24M53.89M
Gross Profit8.37M18.67M27.01M26.66M26.45M
EBITDA1.86M-10.12M1.83M4.38M-23.55M
Net Income-10.13M-17.11M-5.88M-12.69M-30.18M
Balance Sheet
Total Assets9.83M29.15M41.70M60.45M191.38M
Cash, Cash Equivalents and Short-Term Investments4.14M3.88M18.36M25.15M44.89M
Total Debt10.53M12.23M4.49M7.36M29.73M
Total Liabilities16.59M27.74M22.32M34.08M158.48M
Stockholders Equity-6.51M4.36M22.19M29.59M40.23M
Cash Flow
Free Cash Flow2.58M-15.35M-3.84M-24.51M-21.21M
Operating Cash Flow2.62M-854.00K-1.32M-22.93M1.25M
Investing Cash Flow-1.57M-14.46M5.74M2.19M-24.28M
Financing Cash Flow1.06M4.36M-2.75M-5.61M4.83M

Good Fellow Healthcare Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.19
Price Trends
50DMA
0.13
Negative
100DMA
0.16
Negative
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
41.11
Neutral
STOCH
19.68
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Negative. The current price of 0.19 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.13, and above the 200-day MA of 0.15, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 41.11 is Neutral, neither overbought nor oversold. The STOCH value of 19.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
HK$160.98M5.316.92%8.00%-21.50%-43.25%
58
Neutral
HK$56.73M362.73-19.93%-2.91%55.41%
53
Neutral
HK$22.46M-197.60138.68%-20.81%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
HK$84.86M-4.87-27.01%-11.68%-71.01%
42
Neutral
HK$124.00M-20.58-573.79%-30.45%-734.38%
41
Neutral
HK$16.65M-2.2926.12%14.64%-81.95%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.06
100.00%
HK:2293
Bamboos Health Care Holdings Ltd
0.40
-0.15
-27.27%
HK:8161
MediNet Group Ltd.
0.54
0.20
58.82%
HK:8307
Medicskin Holdings Ltd.
0.14
>-0.01
-4.67%
HK:8357
Republic Healthcare Limited
0.14
0.07
91.55%
HK:8437
RMH Holdings Limited
0.25
0.08
47.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026